(Q40854454)

24 September 2017

1 reference

title

Epidemiology, laboratory detection, and therapy of penicillin-resistant streptococcal infections (English)

1 reference

24 September 2017

Jones RN

1

1 reference

PubMed ID

9635236

24 September 2017

Wilson WR

series ordinal

2

1 reference

24 September 2017

1 July 1998

1 reference

Diagnostic Microbiology and Infectious Disease

24 September 2017

1 reference

24 September 2017

31

1 reference

24 September 2017

3

1 reference

24 September 2017

453-459

1 reference

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Genetics of high level penicillin resistance in clinical isolates ofStreptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Emergence of drug-resistant pneumococcal infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Prospective randomized phase II study of intravenous cefpirome 1g or 2g bd in the treatment of hospitalized patients with different infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Antigenic Variation of Penicillin-Binding Proteins from Penicillin-Resistant Clinical Strains of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. The Alexander Project

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900039-X

7 January 2021

10.1016/S0732-8893(98)00039-X

Identifiers

DOI

1 reference

release_pag2n6ng5fg25pligegerpevnq

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pag2n6ng5fg25pligegerpevnq

24 November 2022

mapped directly with Wikidata item

PubMed ID

9635236

1 reference

PubMed ID

9635236